D3 Bio Appoints Dr. Antoine Yver as Independent Board Member
- Written by PR Newswire
![]() |
SHANGHAI, March 14, 2024 /PRNewswire/ -- D3 Bio, an emerging global biotechnology company that focuses on discovery, development, and registration of innovative cancer drugs, welcomes Antoine Yver, MD. ,MSc. as the new independent board member, effective March 4, 2024.
Dr. Yver has 34 years of experience in the global pharmaceutical industry with a...
Read more: D3 Bio Appoints Dr. Antoine Yver as Independent Board Member















